Interestingly, it has been shown that breast cancer (BC) cells inhibit pyruvate kinase (PKM) in pancreatic islet β-cells by secreting miR-122-rich extracellular vesicles, which in turn reduces insulin secretion and leads to dysregulation of glucose homeostasis. This evidence concerns the gene PKM and breast cancer.